# Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction

> **NCT01715883** · PHASE2 · TERMINATED · sponsor: **Gladwin, Mark, MD** · enrollment: 3 (actual)

## Conditions studied

- Primary Graft Dysfunction

## Interventions

- **DRUG:** Sodium Nitrite

## Key facts

- **NCT ID:** NCT01715883
- **Lead sponsor:** Gladwin, Mark, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Lack of support staff
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715883, "Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01715883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*